Hofseth BioCare ASA (HBC) Q3 Revenue Rose to NOK 83.5M

Less than 1 min read

Q3 2026 total operating revenue was NOK 83.5M versus NOK 54.9M a year earlier; EBITDA was positive NOK 4.4M versus negative NOK 21.1M. Cash fell NOK 80.6M during the quarter to NOK 33.6M.

Material Details

| # | Detail | AI Analyst View |

|---|---|---|

| 1 | Revenue NOK 83.5M vs NOK 54.9M YoY | Revenue increased year over year, with the company reporting its highest quarterly revenue. |

| 2 | EBITDA NOK 4.4M vs -NOK 21.1M YoY | EBITDA turned positive year over year, marking a substantial improvement in reported operating performance. |

| 3 | Cash fell NOK 80.6M to NOK 33.6M | The sharp quarterly cash decline and lower ending balance raise liquidity concerns; no explanation for the reduction is provided here. |

| 4 | Liquidity NOK 42.5M vs NOK 67.0M | Including available credit facilities, quarter-end liquidity was lower than the prior-year comparison. |

| 5 | EBIT -NOK 5.7M vs -NOK 30.6M | The operating loss narrowed year over year but remained negative. |

Context by AI Analyst

This is a quarterly results update showing higher revenue and improved profitability alongside a significant cash decline. Further q...